Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

1.950 +0.180 (+10.17%)
Streaming Delayed Price Updated: 12:07 PM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 Next >
Analyst Says Maravai LifeSciences Not Immune From Macro Headwinds As Guidance Lags Consensus
Maravai LifeSciences Holdings Inc's (NASDAQ: MRVI)  
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. 
Via Benzinga
The Latest Analyst Ratings for Maravai LifeSciences
Via Benzinga
The Latest Analyst Ratings for Maravai LifeSciences
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
Via Benzinga
PayPal, 3D Systems, Lucid Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Ohmyhome Limited (NASDAQ: OMH) shares dipped 48% to $13.52 in pre-market... 
Via Benzinga
Maravai LifeSciences (MRVI) Q1 2023 Earnings Call Transcript
MRVI earnings call for the period ending March 31, 2023. 
Via The Motley Fool
5 Value Stocks In The Healthcare Sector
Via Benzinga
Earnings Outlook For Maravai LifeSciences
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Where Maravai LifeSciences Stands With Analysts
Via Benzinga
2 Top Biotech Stocks to Buy In March and Hold Forever
Their price is right, and their future is bright. 
Via The Motley Fool
Don't Miss Out on These 2 Undervalued Stocks With Huge Growth Potential
There isn't much that's stopping them from penetrating their markets globally. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
This Analyst With 85% Accuracy Rate Sees Over 29% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
US stocks closed lower on Friday, with the Dow Jones dropping more than 300 points during the session. 
Via Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
6 Analysts Have This to Say About Maravai LifeSciences
Via Benzinga
Where Maravai LifeSciences Stands With Analysts
Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter: 
Via Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Maravai LifeSciences (MRVI) Q4 2022 Earnings Call Transcript
MRVI earnings call for the period ending December 31, 2022. 
Via The Motley Fool
2 Healthcare Companies That Could Be Acquired Within 5 Years
These stocks are also cheap buys that are down more than 60% from their highs. 
Via The Motley Fool
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
Via Investor's Business Daily
3 Great Growth Stocks Down 20% or More to Buy Now
These beaten-down stocks could be poised for major rebounds. 
Via The Motley Fool
3 Biopharma Stocks That Could Help Make You a Fortune
All three are protected by sales of in-demand products, with more on the way. 
Via The Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
These two companies are facing short-term issues that are likely to give way to long-term success. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 138 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.